SSG
VRDN icon

Summit Securities Group’s Viridian Therapeutics VRDN Stock Holding History

Summit Securities Group’s Portfolio VRDN Stock Details VRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-174
Closed -$2.35K – 1295
2025
Q1 		$2.35K Buy
+174
New +$2.35K ﹤0.01% 530